ILLUMINA, INC.ILMNEarnings & Financial Report
Illumina, Inc. is an American biotechnology company, headquartered in San Diego, California. Incorporated on April 1, 1998, Illumina develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company provides a line of products and services that serves the sequencing, genotyping and gene expression, and proteomics markets, and serves more than 155 countries.
ILMN Q4 2025 Key Financial Metrics
売上高
$1.1B
粗利益
$728.0M
営業利益
$174.0M
純利益
$186.0M
粗利益率
65.9%
営業利益率
15.8%
純利益率
16.8%
前年比成長
-1.6%
EPS
$1.16
資金フロー
ILLUMINA, INC. Q4 2025 Financial Summary
ILLUMINA, INC. reported revenue of $1.1B (down 1.6% YoY) for Q4 2025, with a net profit of $186.0M (up 205.7% YoY) (16.8% margin). Cost of goods sold was $376.0M, operating expenses totaled $554.0M.
Key Financial Metrics
| Total Revenue | $1.1B |
|---|---|
| Net Profit | $186.0M |
| Gross Margin | 65.9% |
| Operating Margin | 15.8% |
| Report Period | Q4 2025 |
Revenue Breakdown
ILLUMINA, INC. Q4 2025 revenue of $1.1B breaks down across 3 segments, led by Sequencing at $1.0B (90.9% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Sequencing | $1.0B | 90.9% |
| Microarray | $101.0M | 9.1% |
| Investee | $7.0M | 0.6% |
ILLUMINA, INC. Revenue by Segment — Quarterly Trend
ILLUMINA, INC. revenue by segment across the last 4 reported quarters, showing how each business line (such as Sequencing and Microarray) has evolved quarter over quarter.
| Segment | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Sequencing | $1.0B | $995.0M | — | — |
| Microarray | $101.0M | $85.0M | — | $97.0M |
| Investee | $7.0M | $7.0M | $4.0M | $2.0M |
ILLUMINA, INC. Annual Revenue by Year
ILLUMINA, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $4.4B). Click any linked year to see what changed vs the prior 10-K.
ILLUMINA, INC. Quarterly Revenue & Net Profit History
ILLUMINA, INC. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 2025 | $1.1B | -1.6% | $186.0M | 16.8% |
| Q3 2025 | $1.1B | -3.5% | $705.0M | 65.3% |
| Q2 2025 | $1.1B | -5.4% | $-2.0B | -178.8% |
| Q1 2025 | $1.1B | -1.0% | $-126.0M | -11.7% |
| Q4 2024 | $1.1B | +3.5% | $-176.0M | -15.7% |
| Q3 2024 | $1.1B | +0.4% | $-754.0M | -67.4% |
| Q2 2024 | $1.2B | +1.2% | $-234.0M | -19.9% |
| Q1 2024 | $1.1B | -11.1% | $3.0M | 0.3% |
損益計算書
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $1.09B | $1.18B | $1.12B | $1.12B | $1.08B | $1.11B | $1.08B | $1.10B |
| 前年比成長 | -11.1% | 1.2% | 0.4% | 3.5% | -1.0% | -5.4% | -3.5% | -1.6% |
貸借対照表
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $11.81B | $11.77B | $10.12B | $10.11B | $10.04B | $6.08B | $6.01B | $6.30B |
| 総負債 | $5.12B | $5.22B | $4.22B | $4.37B | $4.31B | $4.64B | $3.89B | $3.93B |
| 株主資本 | $6.69B | $6.55B | $5.90B | $5.75B | $5.73B | $1.44B | $2.13B | $2.37B |
キャッシュフロー
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $10.0M | $105.0M | $139.0M | $224.0M | $77.0M | $80.0M | $316.0M | $364.0M |